Shinji Kunishima

Summary

Affiliation: National Hospital Organization
Country: Japan

Publications

  1. doi request reprint Bernard-Soulier syndrome caused by a hemizygous GPIbβ mutation and 22q11.2 deletion
    Shinji Kunishima
    Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
    Pediatr Int 55:434-7. 2013
  2. pmc ACTN1 mutations cause congenital macrothrombocytopenia
    Shinji Kunishima
    Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
    Am J Hum Genet 92:431-8. 2013
  3. doi request reprint Differential expression of wild-type and mutant NMMHC-IIA polypeptides in blood cells suggests cell-specific regulation mechanisms in MYH9 disorders
    Shinji Kunishima
    Department of Hemostasis and Thrombosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
    Blood 111:3015-23. 2008
  4. doi request reprint FLNA p.V528M substitution is neither associated with bilateral periventricular nodular heterotopia nor with macrothrombocytopenia
    Shinji Kunishima
    Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, 4 1 1 Sannomaru, Nagoya, Japan
    J Hum Genet 55:844-6. 2010
  5. ncbi request reprint Molecular genetic analysis of a variant Bernard-Soulier syndrome due to compound heterozygosity for two novel glycoprotein Ibbeta mutations
    Shinji Kunishima
    Department of Hemostasis and Thrombosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
    Eur J Haematol 77:501-12. 2006
  6. ncbi request reprint Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations
    Shinji Kunishima
    Department of Haemostasis and Thrombosis, Clinical Research Centre, National Hospital Organization Nagoya Medical Centre, Nagoya, Japan
    Eur J Haematol 78:220-6. 2007
  7. doi request reprint Advances in the understanding of MYH9 disorders
    Shinji Kunishima
    Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
    Curr Opin Hematol 17:405-10. 2010
  8. ncbi request reprint [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders]
    Shinji Kunishima
    Laboratory of Molecular Diagnosis, Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya 460 0001, Japan
    Rinsho Byori 57:365-70. 2009
  9. doi request reprint Identification and characterization of the first large deletion of the MYH9 gene associated with MYH9 disorders
    Shinji Kunishima
    Department of Hemostasis and Thrombosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
    Eur J Haematol 80:540-4. 2008
  10. ncbi request reprint [May-Hegglin anomaly: past and present--novel diagnostic test and new concept of the disease]
    Shinji Kunishima
    Laboratory of Molecular Diagnosis, Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya 460 0001, Japan
    Rinsho Byori 57:54-9. 2009

Collaborators

Detail Information

Publications34

  1. doi request reprint Bernard-Soulier syndrome caused by a hemizygous GPIbβ mutation and 22q11.2 deletion
    Shinji Kunishima
    Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
    Pediatr Int 55:434-7. 2013
    ..2DS) is caused by a microdeletion on chromosome 22, which includes the GPIbβ gene, and is characterized by abnormal development of the pharyngeal apparatus and heart. Thus, patients with 22q11.2DS are obligate carriers for BSS...
  2. pmc ACTN1 mutations cause congenital macrothrombocytopenia
    Shinji Kunishima
    Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
    Am J Hum Genet 92:431-8. 2013
    ..Our findings provide an insight into the pathogenesis of CMTP...
  3. doi request reprint Differential expression of wild-type and mutant NMMHC-IIA polypeptides in blood cells suggests cell-specific regulation mechanisms in MYH9 disorders
    Shinji Kunishima
    Department of Hemostasis and Thrombosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
    Blood 111:3015-23. 2008
    ..We show the differential expression of mutant NMMHC-IIA and postulate that cell-specific regulation mechanisms function in MYH9 disorders...
  4. doi request reprint FLNA p.V528M substitution is neither associated with bilateral periventricular nodular heterotopia nor with macrothrombocytopenia
    Shinji Kunishima
    Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, 4 1 1 Sannomaru, Nagoya, Japan
    J Hum Genet 55:844-6. 2010
    ..Hemizygous controls had a normal platelet count and size. We suggest that p.V528M is neither associated with BPNH nor with thrombocytopenia and giant platelets, and represents a functional polymorphism...
  5. ncbi request reprint Molecular genetic analysis of a variant Bernard-Soulier syndrome due to compound heterozygosity for two novel glycoprotein Ibbeta mutations
    Shinji Kunishima
    Department of Hemostasis and Thrombosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
    Eur J Haematol 77:501-12. 2006
    ..These results suggest that despite disruption of the disulfide linkage between GPIbalpha and GPIbbeta, GPIb/IX is formed, but its stability may be impaired, resulting in low levels of the complex on the platelet membranes...
  6. ncbi request reprint Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations
    Shinji Kunishima
    Department of Haemostasis and Thrombosis, Clinical Research Centre, National Hospital Organization Nagoya Medical Centre, Nagoya, Japan
    Eur J Haematol 78:220-6. 2007
    ..The aim of our study was to determine the haematological characteristics of MYH9 disorders as a result of R702 mutations to aid in making a proper diagnosis...
  7. doi request reprint Advances in the understanding of MYH9 disorders
    Shinji Kunishima
    Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
    Curr Opin Hematol 17:405-10. 2010
    ..The present review summarizes the recent advances in genetic diagnosis and our understanding of the pathogenetic mechanisms of MYH9 mutations and the development of nonhematological complications...
  8. ncbi request reprint [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders]
    Shinji Kunishima
    Laboratory of Molecular Diagnosis, Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya 460 0001, Japan
    Rinsho Byori 57:365-70. 2009
    ..Patients initially diagnosed with MHA and/or Sebastian syndrome can subsequently develop nephritis, deafness, and/or cataracts. Thus, the development of Alport manifestations should be monitored by careful follow-up...
  9. doi request reprint Identification and characterization of the first large deletion of the MYH9 gene associated with MYH9 disorders
    Shinji Kunishima
    Department of Hemostasis and Thrombosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
    Eur J Haematol 80:540-4. 2008
    ..Immunoblot analysis showed a small, abnormal protein in neutrophils but not in platelets. This is the first report of a large deletion of the MYH9 gene leading to the development of MYH9 disorders...
  10. ncbi request reprint [May-Hegglin anomaly: past and present--novel diagnostic test and new concept of the disease]
    Shinji Kunishima
    Laboratory of Molecular Diagnosis, Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya 460 0001, Japan
    Rinsho Byori 57:54-9. 2009
    ..We showed the differential expression of mutant NMMHC-IIA, and postulated that cell-specific regulation mechanisms function in MYH9 disorders...
  11. doi request reprint Heterozygous ITGA2B R995W mutation inducing constitutive activation of the αIIbβ3 receptor affects proplatelet formation and causes congenital macrothrombocytopenia
    Shinji Kunishima
    Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, 4 1 1 Sannomaru, Naka ku, Nagoya, Japan
    Blood 117:5479-84. 2011
    ..We propose that activating mutations in ITGA2B and ITGB3 represent the etiology of a subset of congenital macrothrombocytopenias...
  12. ncbi request reprint Novel heterozygous missense mutation in the second leucine rich repeat of GPIbalpha affects GPIb/IX/V expression and results in macrothrombocytopenia in a patient initially misdiagnosed with idiopathic thrombocytopenic purpura
    Shinji Kunishima
    Department of Hemostasis and Thrombosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
    Eur J Haematol 76:348-55. 2006
    ..These findings suggest that null expression of the mutant GPIbalpha causes decreased density of the complex and results in macrothrombocytopenia...
  13. doi request reprint Mutation of the beta1-tubulin gene associated with congenital macrothrombocytopenia affecting microtubule assembly
    Shinji Kunishima
    Department of Hemostasis and Thrombosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
    Blood 113:458-61. 2009
    ..Alternatively, mutant beta1-tubulin may not be transported from the megakaryocytes into platelets. W318 beta1-tubulin may interfere with normal platelet production, resulting in macrothrombocytopenia...
  14. ncbi request reprint Detection of unique neutrophil non-muscle myosin heavy chain-A localization by immunofluorescence analysis in MYH9 disorder presented with macrothrombocytopenia without leukocyte inclusions and deafness
    Shinji Kunishima
    Department of Hemostasis and Thrombosis, Clinical Research Center, Nagoya Medical Center, Nagoya, Japan
    Eur J Haematol 74:1-5. 2005
    ..These results further support the usefulness of immunofluorescence analysis in differential diagnosis of MYH9 disorders...
  15. ncbi request reprint First description of somatic mosaicism in MYH9 disorders
    Shinji Kunishima
    Department of Haemostasis and Thrombosis, Clinical Research Centre, National Hospital Organization Nagoya Medical Centre, Nagoya, Japan
    Br J Haematol 128:360-5. 2005
    ..Mosaicism might account for some de novo mutations in MYH9 disorders...
  16. ncbi request reprint Congenital macrothrombocytopenias
    Shinji Kunishima
    Department of Hemostasis and Thrombosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
    Blood Rev 20:111-21. 2006
    ..This review summarizes the current knowledge on the clinical and laboratory features of common congenital macrothrombocytopenias and discusses how that knowledge aids in making a proper diagnosis...
  17. ncbi request reprint Further characterization of anti-platelet monoclonal antibody HPL5 as anti-glycoprotein V antibody
    Shinji Kunishima
    Department of Hemostasis and Thrombosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya University School of Health Sciences, Nagoya, Japan
    Acta Haematol 115:128-30. 2006
  18. doi request reprint A novel splice site mutation in intron C of PROS1 leads to markedly reduced mutant mRNA level, absence of thrombin-sensitive region, and impaired secretion and cofactor activity of mutant protein S
    Hiromi Okada
    Department of Hemostasis and Thrombosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, 4 1 1 San nomaru, Naka ku, Nagoya 460 0001, Japan
    Thromb Res 125:e246-50. 2010
    ....
  19. ncbi request reprint Historical hematology: May-Hegglin anomaly
    Hidehiko Saito
    Nagoya Central Hospital, Nagoya, Japan
    Am J Hematol 83:304-6. 2008
    ..Current interest is centered upon the mechanisms by which a single mutation causes a variety of phenotypes...
  20. doi request reprint Thrombosis from a prothrombin mutation conveying antithrombin resistance
    Yuhri Miyawaki
    Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan
    N Engl J Med 366:2390-6. 2012
    ..The Leu596 substitution caused a gain-of-function mutation in the prothrombin gene, resulting in resistance to antithrombin and susceptibility to thrombosis...
  21. doi request reprint TUBB1 mutation disrupting microtubule assembly impairs proplatelet formation and results in congenital macrothrombocytopenia
    Shinji Kunishima
    Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
    Eur J Haematol 92:276-82. 2014
    ..Deficient functional microtubules might lead to defective proplatelet formation and abnormal protrusion-like platelet release, resulting in congenital macrothrombocytopenia. ..
  22. pmc Rhof promotes murine marginal zone B cell development
    Mayuko Kishimoto
    Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan Department of Mechanism of Aging, Research Institute, National Center for Geriatrics and Gerontology, Obu, Japan Department of Clinical Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan
    Nagoya J Med Sci 76:293-305. 2014
    ..Furthermore, we demonstrated that RhoF was dispensable for stromal cell-derived factor-1α- and B lymphocyte chemoattractant-induced B cell migration. These results suggest that RhoF promotes MZ B cell development in the spleen. ..
  23. doi request reprint Genotype-phenotype Correlation of the p.R1165C Mutation in the MYH9 Disorder: Report of a Japanese Pedigree
    Satomi Okano
    Department of Pediatrics, Fukagawa Municipal Hospital, Fukagawa Department of Pediatrics, Asahikawa Medical University, Asahikawa Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
    J Pediatr Hematol Oncol 37:e352-5. 2015
    ..R1165C is associated with variable expression of nonhematological manifestations. Careful detection of leukocyte inclusion bodies in peripheral blood smears is necessary to prevent misdiagnosis. ..
  24. doi request reprint Accumulation of MYH9 mRNA at leukocyte inclusion bodies in MYH9 disorders
    Shinji Kunishima
    Eur J Haematol 81:325-6. 2008
  25. ncbi request reprint Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutations
    Shinji Kunishima
    Japanese Red Cross Aichi Blood Center, Seto, Japan
    Lab Invest 83:115-22. 2003
    ..Immunofluorescence analysis of neutrophil NMMHCA is useful as a screening test for the clear hematopathologic classification of MYH9 disorders...
  26. ncbi request reprint [May-Hegglin anomaly--from genome research to clinical laboratory]
    Shinji Kunishima
    Japanese Red Cross Aichi Blood Center, Seto 489 8555
    Rinsho Byori 51:898-904. 2003
    ..Immunofluorescence analysis of neutrophil NMMHCA is useful as a novel screening test for the differential diagnosis of macrothrombocytopenia and clear hematopathological classification of MYH9 disorders...
  27. ncbi request reprint A unique immunofluorescence method promotes accurate diagnosis in MYH9 disorders: a case report
    Miyako Yoshinari
    Department of Pediatric Oncology, Institute of Development, Aging, and Cancer, Tohoku University, Sendai, Japan
    J Pediatr Hematol Oncol 26:579-83. 2004
    ..MYH9 disorders may be much more common than previously realized if accurately diagnosed...
  28. ncbi request reprint Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological, and otological studies of heterozygous KO mice
    Tadashi Matsushita
    Department of Hematology, Nagoya University Graduate School of Medicine, Japan
    Biochem Biophys Res Commun 325:1163-71. 2004
    ..Such observation may parallel the diverse expression of Alport's manifestations of human individuals with MYH9 disorders and suggest the limited requirement of the gene for maintenance and function of specific organs...
  29. ncbi request reprint Identification of a novel MYH9 mutation in a patient with May-Hegglin anomaly
    Keisuke Otsubo
    Pediatr Blood Cancer 47:968-9. 2006
  30. ncbi request reprint Bernard-Soulier syndrome due to GPIX W127X mutation in Japan is frequently misdiagnosed as idiopathic thrombocytopenic purpura
    Shinji Kunishima
    Int J Hematol 83:366-7. 2006
  31. ncbi request reprint First Turkish case of Bernard-Soulier syndrome associated with GPIX N45S
    Necati Dağistan
    Department of Hematology, Golcuk Military Hospital, Golcuk, Turkey
    Acta Haematol 118:146-8. 2007
    ..This is the first non-Caucasian Turkish BSS case due to GPIX N45S and is likely the result of a recurrent mutational event...
  32. doi request reprint Characterization of a patient with atypical amegakaryocytic thrombocytopenia
    Sachiko Kanaji
    Division of Medical Biochemistry, Department of Biomolecular Sciences, Saga Medical School, Saga, Japan
    Eur J Haematol 80:361-4. 2008
    ..To our knowledge, this is the first report that describes a case of amegakaryocytic thrombocytopenia that is not caused by a mutation in MPL and demonstrates the severe impairment of GPVI expression on platelets...
  33. ncbi request reprint Novel nonsense mutation in the platelet glycoprotein Ibbeta gene associated with Bernard-Soulier syndrome
    Shinji Kunishima
    Japanese Red Cross Aichi Blood Center, Seto, Japan
    Am J Hematol 71:279-84. 2002
    ....
  34. ncbi request reprint Genetic abnormalities of Bernard-Soulier syndrome
    Shinji Kunishima
    Int J Hematol 76:319-27. 2002
    ..In this review, we summarize recent advances in the molecular basis of BSS with special emphasis on giant platelets and the genetic characteristics of Japanese BSS...